Role of interim-PET (I-PET) in diffuse large B-cell Lymphoma (DLBCL) is controversial. To determine predictive value of I-PET on progression-free survival (PFS), we enrolled 88 first-line DLBCL patients treated with 6-8 R-CHOP courses regardless of I-PET. PET/CT were performed at diagnosis, after 2 to 4 courses and at the end of therapy with central reviewing according to visual dichotomous criteria. Results are as follows: I-PET, 72% negative, 28% positive; final-PET (F-PET), 88% negative, 12% positive; clinical complete response 90%. Concordance between clinical response and F-PET negativity was 97% because of 2 false positive. With a median follow-up of 26.2 months, 2-year overall survival and PFS were 91% and 77%, respectively. Two-year PFS for I-PET and F-PET negative versus positive were as follows: I-PET 85% versus 72% (P = .0475); F-PET 83% versus 64% (P < .001). Because of a small number of events, 2 independent bivariate Cox models were tested for PFS. In model 1, F-PET contradicted I-PET (hazard ratio [HR] = 5.03, P = .015 vs 1.27, P = 691); in model 2, F-PET (HR = 4.54) and International propnostic Index score (HR = 5.36, P = .001) remained independent prognostic factors. In conclusion, positive I-PET is not predictive of a worse outcome in DLBCL; larger prospective studies and harmonization of I-PET reading criteria are needed.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1182/blood-2011-06-359943 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
A Method for Validating PET and SPECT Cameras for Quantitative Clinical Imaging Trials Using Novel Radionuclides.
J Nucl Med
January 2025
Department of Nuclear Medicine, Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia.
Our aim is to report methodology that has been developed to calibrate and verify PET and SPECT quantitative image accuracy and quality assurance for use with nonstandard radionuclides, especially with longer half-lives, in clinical imaging trials. Procedures have been developed for quantitative PET and SPECT image calibration for use in clinical trials. The protocol uses a 3-step approach: check quantitative accuracy with a previously calibrated radionuclide in a simple geometry, check the novel trial radionuclide in the same geometry, and check the novel radionuclide in a more challenging, complex geometry (the National Electrical Manufacturers Association [NEMA] NU-2 International Electrotechnical Commission [IEC] image-quality phantom).
View Article and Find Full Text PDFPrognostic value of interim PET/CT in GCB and non-GCB DLBCL: comparison of the Deauville five-point scale and the ΔSUVmax method.
BMC Cancer
December 2024
Department of Nuclear Medicine, School of Medicine, Shanghai General Hospital, Shanghai JiaoTong University, Shanghai, 200080, China.
Background: This study aimed to identify the prognostic value of interim F-FDG PET/CT (I-PET) for germinal center B-cell-like (GCB) and non-GCB diffuse large B-cell lymphoma (DLBCL), respectively.
Methods: Baseline F-FDG PET/CT (B-PET) and I-PET scans were performed in 112 patients with DLBCL. The prognostic value of I-PET using the Deauville five-point scale (D-5PS) criteria or percentage decrease in SUVmax (∆SUVmax) for GCB and non-GCB DLBCL were evaluated.
Advancing F NMR Prediction of Metal-Fluoride Complexes in Solution: Insights from Ab Initio Molecular Dynamics.
J Phys Chem A
December 2024
Hylleraas Centre for Quantum Molecular Sciences, Department of Chemistry, University of Oslo, 0315 Oslo, Norway.
Article Synopsis
- F NMR parameters serve as important tools for investigating metal-fluoride complexes, while accurate chemical shift predictions are enhanced through quantum chemical calculations.
- The study focuses on developing a computational method using ab initio molecular dynamics to better predict F NMR chemical shifts in square-planar nickel-fluoride complexes, specifically analyzing the -[NiF(2,3,4,5-CFI)(PEt)] complex in a benzene solution.
- It highlights the significance of considering dynamic conformational flexibility and intramolecular interactions to achieve reliable predictions, while also addressing the challenges of incorporating solvation effects in these calculations.
Detection and quantification of small and low-uptake lesions for differentiated thyroid carcinoma using non-time-of-flight iodine-124 PET/MRI.
Med Phys
November 2024
High-Field and Hybrid MR Imaging, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
Article Synopsis
- 124-iodine (I) is essential for PET diagnostics and therapy in differentiated thyroid cancer (DTC), but detecting small lesions (<10 mm) poses significant challenges due to low iodine uptake.
- The study aimed to evaluate the effectiveness of non-time-of-flight (TOF) PET/MRI in identifying and quantifying small DTC lymph node lesions under difficult imaging conditions.
- Results indicated that longer acquisition times, higher activity concentrations, and advanced reconstruction algorithms improved lesion visibility, with the smallest detectable size of 3.7 mm only visible under optimal settings.
Impaired mitochondrial function in bipolar disorder and alcohol use disorder: a case study using F-BCPP-EF PET imaging of mitochondrial Complex I.
Psychoradiology
September 2024
Department of Neurology, University of Michigan, Ann Arbor, MI 48109, USA.
Background: With bipolar disorder (BD) having a lifetime prevalence of 4.4% and a significant portion of patients being chronically burdened by symptoms, there has been an increased focus on uncovering new targets for intervention in BD. One area that has shown early promise is the mitochondrial hypothesis.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!